175 related articles for article (PubMed ID: 26293198)
1. Safety and efficacy of commonly used antiemetics.
Hendren G; Aponte-Feliciano A; Kovac A
Expert Opin Drug Metab Toxicol; 2015; 11(11):1753-67. PubMed ID: 26293198
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : a systematic review].
Benze G; Geyer A; Alt-Epping B; Nauck F
Schmerz; 2012 Sep; 26(5):481-99. PubMed ID: 22983450
[TBL] [Abstract][Full Text] [Related]
3. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
Goodman M
Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
[TBL] [Abstract][Full Text] [Related]
5. Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis.
Tricco AC; Soobiah C; Antony J; Hemmelgarn B; Moher D; Hutton B; Straus SE
Syst Rev; 2013 Jun; 2():46. PubMed ID: 23810058
[TBL] [Abstract][Full Text] [Related]
6. Antiemetic therapy.
Axelrod RS
Compr Ther; 1997 Aug; 23(8):539-45. PubMed ID: 9283743
[TBL] [Abstract][Full Text] [Related]
7. Granisetron: an update on its clinical use in the management of nausea and vomiting.
Aapro M
Oncologist; 2004; 9(6):673-86. PubMed ID: 15561811
[TBL] [Abstract][Full Text] [Related]
8. Management of chemotherapy-induced nausea and vomiting.
Tortorice PV; O'Connell MB
Pharmacotherapy; 1990; 10(2):129-45. PubMed ID: 2190193
[TBL] [Abstract][Full Text] [Related]
9. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.
Mahesh R; Perumal RV; Pandi PV
Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895
[TBL] [Abstract][Full Text] [Related]
10. 5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?
Aapro M; Blower P
Cancer; 2005 Jul; 104(1):1-18. PubMed ID: 15929119
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.
Kimura H; Yamamoto N; Shirai T; Nishida H; Hayashi K; Tanzawa Y; Takeuchi A; Igarashi K; Inatani H; Shimozaki S; Kato T; Aoki Y; Higuchi T; Tsuchiya H
Cancer Med; 2015 Mar; 4(3):333-41. PubMed ID: 25533447
[TBL] [Abstract][Full Text] [Related]
12. Medicinal plants as antiemetics in the treatment of cancer: a review.
Haniadka R; Popouri S; Palatty PL; Arora R; Baliga MS
Integr Cancer Ther; 2012 Mar; 11(1):18-28. PubMed ID: 21821652
[TBL] [Abstract][Full Text] [Related]
13. Use of dexamethasone with 5-HT3-receptor antagonists for chemotherapy-induced nausea and vomiting.
Perez EA
Cancer J Sci Am; 1998; 4(2):72-7. PubMed ID: 9532406
[TBL] [Abstract][Full Text] [Related]
14. Aprepitant for the management of refractory emesis in a patient with a small bowel carcinoid tumor.
Kyeremateng S; Boland JW
J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):135-7. PubMed ID: 24833205
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of nausea nad vomiting in palliative medicine].
Bausewein C
Z Arztl Fortbild Qualitatssich; 2000 Sep; 94(7):569-73. PubMed ID: 11048341
[TBL] [Abstract][Full Text] [Related]
16. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
de Wit R; Aapro M; Blower PR
Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians' practice.
Giusti R; Mazzotta M; Filetti M; Daniele G; Tsukuura H; Ficorella C; Porzio G; Marchetti P; Verna L
Support Care Cancer; 2019 Sep; 27(9):3531-3535. PubMed ID: 30684048
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.
Srivastava M; Brito-Dellan N; Davis MP; Leach M; Lagman R
J Pain Symptom Manage; 2003 Jun; 25(6):578-82. PubMed ID: 12782438
[TBL] [Abstract][Full Text] [Related]
19. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics.
Hsu ES
Am J Ther; 2010; 17(5):476-86. PubMed ID: 20844345
[TBL] [Abstract][Full Text] [Related]
20. Nausea and vomiting in advanced cancer.
Ang SK; Shoemaker LK; Davis MP
Am J Hosp Palliat Care; 2010 May; 27(3):219-25. PubMed ID: 20197557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
